SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009702
Filing Date
2022-05-12
Accepted
2022-05-12 16:29:14
Documents
91
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fdmt-20220331.htm   iXBRL 10-Q 2974802
2 EX-10.1 fdmt-ex10_1.htm EX-10.1 40359
3 EX-31.1 fdmt-ex31_1.htm EX-31.1 24360
4 EX-31.2 fdmt-ex31_2.htm EX-31.2 24280
5 EX-32.1 fdmt-ex32_1.htm EX-32.1 15376
  Complete submission text file 0000950170-22-009702.txt   11123789

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fdmt-20220331.xsd EX-101.SCH 74305
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fdmt-20220331_lab.xml EX-101.LAB 524293
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fdmt-20220331_pre.xml EX-101.PRE 419008
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fdmt-20220331_def.xml EX-101.DEF 251906
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fdmt-20220331_cal.xml EX-101.CAL 44251
85 EXTRACTED XBRL INSTANCE DOCUMENT fdmt-20220331_htm.xml XML 2208104
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39782 | Film No.: 22918295
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences